Astrocytic JWA Expression is Essential to Dopaminergic Neuron Survival in the Pathogenesis of Parkinson's Disease. (17th March 2014)
- Record Type:
- Journal Article
- Title:
- Astrocytic JWA Expression is Essential to Dopaminergic Neuron Survival in the Pathogenesis of Parkinson's Disease. (17th March 2014)
- Main Title:
- Astrocytic JWA Expression is Essential to Dopaminergic Neuron Survival in the Pathogenesis of Parkinson's Disease
- Authors:
- Miao, Shu‐Han
Sun, Hong‐Bin
Ye, Yang
Yang, Jing‐Jing
Shi, Yao‐Wei
Lu, Ming
Hu, Gang
Zhou, Jian‐Wei - Abstract:
- <abstract abstract-type="main" id="cns12249-abs-0001"> <title>Summary</title> <sec id="cns12249-sec-0001" sec-type="section"> <title>Aims</title> <p>To investigate the role of astrocytic JWA expression in dopaminergic (DA) neuron degeneration and in the pathogenesis of Parkinson's disease (PD).</p> </sec> <sec id="cns12249-sec-0002" sec-type="section"> <title>Methods</title> <p>Conditional astrocytic JWA null (JWA<sup>∆2/∆2</sup>/GFAP‐Cre) mice and U251 glioma cells were used to evaluate the effects of JWA gene on DA neuron degeneration. The oxidative stress‐driven molecular events were determined in both <italic>in vivo</italic> and <italic>in vitro</italic> models.</p> </sec> <sec id="cns12249-sec-0003" sec-type="section"> <title>Results</title> <p>Conditional astrocytic JWA knockout resulted in significant activation of astrocytes measured by increase in glial fibrillary acidic protein‐positive cells (1.34 × 10<sup>3</sup> ± 74.5 vs. 8.44 × 10<sup>3</sup> ± 1.35 × 10<sup>3</sup>, <italic>P </italic>&lt;<italic> </italic>0.01) in mouse substantia nigra, accompanied by loss of DA neurons (1.03 × 10<sup>4</sup> ± 238 vs. 6.17 × 10<sup>3</sup> ± 392, <italic>P </italic>&lt;<italic> </italic>0.001). Deficiency of JWA significantly aggravated reactive oxygen species (ROS) accumulation in substantia nigra compared with the wild‐type mice. Increasing JWA expression in U251 glioma cells inhibited ROS with a concomitant increase in intracellular glutathione. Furthermore,<abstract abstract-type="main" id="cns12249-abs-0001"> <title>Summary</title> <sec id="cns12249-sec-0001" sec-type="section"> <title>Aims</title> <p>To investigate the role of astrocytic JWA expression in dopaminergic (DA) neuron degeneration and in the pathogenesis of Parkinson's disease (PD).</p> </sec> <sec id="cns12249-sec-0002" sec-type="section"> <title>Methods</title> <p>Conditional astrocytic JWA null (JWA<sup>∆2/∆2</sup>/GFAP‐Cre) mice and U251 glioma cells were used to evaluate the effects of JWA gene on DA neuron degeneration. The oxidative stress‐driven molecular events were determined in both <italic>in vivo</italic> and <italic>in vitro</italic> models.</p> </sec> <sec id="cns12249-sec-0003" sec-type="section"> <title>Results</title> <p>Conditional astrocytic JWA knockout resulted in significant activation of astrocytes measured by increase in glial fibrillary acidic protein‐positive cells (1.34 × 10<sup>3</sup> ± 74.5 vs. 8.44 × 10<sup>3</sup> ± 1.35 × 10<sup>3</sup>, <italic>P </italic>&lt;<italic> </italic>0.01) in mouse substantia nigra, accompanied by loss of DA neurons (1.03 × 10<sup>4</sup> ± 238 vs. 6.17 × 10<sup>3</sup> ± 392, <italic>P </italic>&lt;<italic> </italic>0.001). Deficiency of JWA significantly aggravated reactive oxygen species (ROS) accumulation in substantia nigra compared with the wild‐type mice. Increasing JWA expression in U251 glioma cells inhibited ROS with a concomitant increase in intracellular glutathione. Furthermore, suppression of IKK<italic>β</italic>‐nuclear factor (NF)‐<italic>κ</italic>B signaling pathway was shown to regulate JWA in a PD model.</p> </sec> <sec id="cns12249-sec-0004" sec-type="section"> <title>Conclusions</title> <p>The JWA gene exerts neuroprotective roles against DA neuronal degeneration via modulating intracellular redox status and NF‐<italic>κ</italic>B signaling pathway and is a potential treatment target for PD.</p> </sec> </abstract> … (more)
- Is Part Of:
- CNS neuroscience & therapeutics. Volume 20:Number 8(2014)
- Journal:
- CNS neuroscience & therapeutics
- Issue:
- Volume 20:Number 8(2014)
- Issue Display:
- Volume 20, Issue 8 (2014)
- Year:
- 2014
- Volume:
- 20
- Issue:
- 8
- Issue Sort Value:
- 2014-0020-0008-0000
- Page Start:
- 754
- Page End:
- 762
- Publication Date:
- 2014-03-17
- Subjects:
- Neuropharmacology -- Periodicals
Central nervous system -- Diseases -- Effect of drugs on -- Periodicals
612.8 - Journal URLs:
- http://www.blackwell-synergy.com/loi/cnsnt ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cns.12249 ↗
- Languages:
- English
- ISSNs:
- 1755-5930
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.140000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3241.xml